These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 37824806)

  • 1. Caring for Patients With Opioid Misuse or Substance Use Disorders in Hospice: A National Survey.
    Langmann GA; Childers J; Merlin JS
    J Palliat Med; 2024 Feb; 27(2):209-215. PubMed ID: 37824806
    [No Abstract]   [Full Text] [Related]  

  • 2. Barriers to Buprenorphine Prescribing for Opioid Use Disorder in Hospice and Palliative Care.
    Janet Ho J; Jones KF; Sager Z; Neale K; Childers JW; Loggers E; Merlin JS
    J Pain Symptom Manage; 2022 Aug; 64(2):119-127. PubMed ID: 35561938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polysubstance use and association with opioid use disorder treatment in the US Veterans Health Administration.
    Lin LA; Bohnert ASB; Blow FC; Gordon AJ; Ignacio RV; Kim HM; Ilgen MA
    Addiction; 2021 Jan; 116(1):96-104. PubMed ID: 32428386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative Effectiveness Associated With Buprenorphine and Naltrexone in Opioid Use Disorder and Cooccurring Polysubstance Use.
    Xu KY; Mintz CM; Presnall N; Bierut LJ; Grucza RA
    JAMA Netw Open; 2022 May; 5(5):e2211363. PubMed ID: 35536575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dying on Hospice in the Midst of an Opioid Crisis: What Should We Do Now?
    Gabbard J; Jordan A; Mitchell J; Corbett M; White P; Childers J
    Am J Hosp Palliat Care; 2019 Apr; 36(4):273-281. PubMed ID: 30352517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. "I feel uncomfortable 'calling a patient out'": educational needs of palliative medicine fellows in managing opioid misuse.
    Childers JW; Arnold RM
    J Pain Symptom Manage; 2012 Feb; 43(2):253-60. PubMed ID: 21680141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Top Ten Tips Palliative Care Clinicians Should Know About Buprenorphine.
    Neale KJ; Weimer MB; Davis MP; Jones KF; Kullgren JG; Kale SS; Childers J; Broglio K; Merlin JS; Peck S; Francis SY; Bango J; Jones CA; Sager Z; Ho JJ
    J Palliat Med; 2023 Jan; 26(1):120-130. PubMed ID: 36067137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treating opioid use disorder in veterans with co-occurring substance use: a qualitative study with buprenorphine providers in primary care, mental health, and pain settings.
    Frost MC; Soyer EM; Achtmeyer CE; Hawkins EJ; Glass JE; Hallgren KA; Williams EC
    Addict Sci Clin Pract; 2023 May; 18(1):26. PubMed ID: 37143162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary Addiction Medicine Skills for Hospice and Palliative Medicine Physicians: A Modified Delphi Study.
    Chua IS; Fratt E; Ho JJ; Roldan CS; Gundersen DA; Childers J
    J Pain Symptom Manage; 2021 Oct; 62(4):720-729. PubMed ID: 33677071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Addressing the opioid crisis: An assessment of clinicians' training experience, practices, and attitudes within a large healthcare organization.
    Kirane H; Drits E; Ahn S; Kapoor S; Morgenstern J; Conigliaro J; Enden J
    J Opioid Manag; 2019; 15(3):193-204. PubMed ID: 31343721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening and Assessment of Substance Use in Hospice Care: Examining Content from a National Sample of Psychosocial Assessments.
    Sacco P; Cagle JG; Moreland ML; Camlin EAS
    J Palliat Med; 2017 Aug; 20(8):850-856. PubMed ID: 28333571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Substance use, substance use disorders, and treatment in adolescent and young adult cancer survivors-Results from a national survey.
    Ji X; Cummings JR; Mertens AC; Wen H; Effinger KE
    Cancer; 2021 Sep; 127(17):3223-3231. PubMed ID: 33974717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Managing Chronic Pain in Cancer Survivors Prescribed Long-Term Opioid Therapy: A National Survey of Ambulatory Palliative Care Providers.
    Merlin JS; Patel K; Thompson N; Kapo J; Keefe F; Liebschutz J; Paice J; Somers T; Starrels J; Childers J; Schenker Y; Ritchie CS
    J Pain Symptom Manage; 2019 Jan; 57(1):20-27. PubMed ID: 30342243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of prenatal substance use policies on commercially insured pregnant females with opioid use disorder.
    Tabatabaeepour N; Morgan JR; Jalali A; Kapadia SN; Meinhofer A
    J Subst Abuse Treat; 2022 Sep; 140():108800. PubMed ID: 35577664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk for prescription opioid misuse among patients with a history of substance use disorder.
    Morasco BJ; Turk DC; Donovan DM; Dobscha SK
    Drug Alcohol Depend; 2013 Jan; 127(1-3):193-9. PubMed ID: 22818513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Consensus-Based Guidance on Opioid Management in Individuals With Advanced Cancer-Related Pain and Opioid Misuse or Use Disorder.
    Fitzgerald Jones K; Khodyakov D; Arnold R; Bulls H; Dao E; Kapo J; Meier D; Paice J; Liebschutz J; Ritchie C; Merlin J
    JAMA Oncol; 2022 Aug; 8(8):1107-1114. PubMed ID: 35771550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of polysubstance use disorder with treatment quality among Medicaid beneficiaries with opioid use disorder.
    Smart R; Kim JY; Kennedy S; Tang L; Allen L; Crane D; Mack A; Mohamoud S; Pauly N; Perez R; Donohue J
    J Subst Abuse Treat; 2023 Jan; 144():108921. PubMed ID: 36327615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Injectable naltrexone, oral naltrexone, and buprenorphine utilization and discontinuation among individuals treated for opioid use disorder in a United States commercially insured population.
    Morgan JR; Schackman BR; Leff JA; Linas BP; Walley AY
    J Subst Abuse Treat; 2018 Feb; 85():90-96. PubMed ID: 28733097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An Appraisal of Using Opioids in Patients with Opioid Use Disorder.
    Smith RG
    J Am Podiatr Med Assoc; 2023; 113(3):. PubMed ID: 37463194
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.